PRQR – proqr therapeutics n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
12/20
07:35 am
prqr
Low
Is There An Opportunity With ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 37% Undervaluation? [Yahoo! Finance]
12/12
09:34 am
prqr
Low
ProQR Therapeutics (NASDAQ: PRQR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $8.00 price target on the stock.
12/12
08:26 am
prqr
Medium
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
12/12
08:26 am
prqr
Medium
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
12/11
07:10 am
prqr
Low
ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration [Yahoo! Finance]
11/7/2024
07:00 am
prqr
-0.8%
BEAT
8/8/2024
07:00 am
prqr
11.1%
BEAT
12/12
09:34 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Low
-2.4%
12/12
09:34 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Low
-2.4%
12/12
09:17 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Medium
-3.8%
12/12
09:17 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Medium
-3.8%
12/12
08:26 am
Reiterates
Buy
Buy
HC Wainwright
Medium
-4.6%
12/12
08:23 am
prqr
Medium
Form 6-K/A ProQR Therapeutics N.V. For: Dec 12
12/11
04:02 pm
prqr
Low
Form 6-K ProQR Therapeutics N.V. For: Dec 11
12/11
07:08 am
prqr
Low
Form 6-K ProQR Therapeutics N.V. For: Dec 11
12/10
08:05 am
prqr
Medium
Form 6-K ProQR Therapeutics N.V. For: Dec 10
12/5
08:05 am
prqr
Neutral
Form 6-K ProQR Therapeutics N.V. For: Dec 05
Show more
Top News Gainers
3/13 ProQR Therapeutics NV (NASDAQ: PRQR) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 17.4%
10/16 ProQR prices stock offering; shares down 12% after hours [Seeking Alpha] 15.4%
7/12 ProQR Therapeutics NV (NASDAQ: PRQR) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 13.5%
11/20 ProQR Therapeutics NV (NASDAQ: PRQR) had its price target lowered by analysts at Citigroup Inc from $40.00 to $33.00. They now have a "buy" rating on the stock. 13.3%
11/1 ProQR Therapeutics NV (NASDAQ: PRQR) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 11.4%
2/6 ProQR Therapeutics Teams Up with the Foundation Fighting Blindness and Blueprint Genetics to Support the My Retina Tracker® Program for People Living with Inherited Retinal Diseases 10.5%
3/25 ProQR to Present Findings from Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome 10.4%
10/10 ProQR Therapeutics NV (NASDAQ: PRQR) had its price target raised by analysts at Citigroup Inc from $34.00 to $40.00. They now have a "buy" rating on the stock. 8.0%
7/29 Form 6-K ProQR Therapeutics N.V. For: Jul 29 6.8%
5/24 ProQR Therapeutics NV (NASDAQ: PRQR) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 6.8%
Top News Decliners
3/31 Form 6-K ProQR Therapeutics N.V. For: Mar 31 -21.7%
3/14 ProQR Therapeutics NV (NASDAQ: PRQR) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -10.6%
1/30 Form 6-K ProQR Therapeutics N.V. For: Jan 30 -10.3%
10/10 Form 6-K ProQR Therapeutics N.V. For: Oct 10 -9.7%
11/8 Form SC 13G ProQR Therapeutics N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP -9.3%
11/18 ProQR to Present at Upcoming Scientific Conferences -9.3%
8/14 ProQR Therapeutics NV (NASDAQ: PRQR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $10.00 price target on the stock. -8.1%
11/28 ProQR Therapeutics NV (NASDAQ: PRQR) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -7.2%
2/26 Form 6-K ProQR Therapeutics N.V. For: Aug 31 -6.8%
9/30 ProQR to Present at Two Investor Conferences in October -6.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3